SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
Open Access
Abstract
SARS-CoV-2 infection may affect the liver in healthy individuals but also influences the course of COVID-19 in patients with chronic liver disease (CLD). As described in healthy individuals, a strong SARS-CoV-2-specific adaptive immune response is important for the outcome of COVID-19, however, knowledge on the adaptive immune response in CLD is limited. Here, we review the clinical and immunological features of SARS-CoV-2 infection in individuals with CLD. Acute liver injury occurs in many cases of SARS-CoV-2 infection and may be induced by multiple factors, such as cytokines, direct viral infection or toxic effects of COVID-19 drugs. In individuals with CLD, SARS-CoV-2 infection may have a more severe course and promote decompensation and particularly in patients with cirrhosis. Compared with healthy individuals, the SARS-CoV-2-specific adaptive immune responses is impaired in patients with CLD after both, natural infection and vaccination but improves at least partially after booster vaccination. Following SARS-CoV-2 vaccination, rare cases of acute vaccine-induced liver injury and the development of autoimmune-like hepatitis have been reported. However, the concomitant elevation of liver enzymes is reversible under steroid treatment.Keywords
Funding Information
- Helmholtz Association (KA1-Co-02 “COVIPA”)
- Deutsche Forschungsgemeinschaft (256073931, 272983813, 413517907)
This publication has 146 references indexed in Scilit:
- Transmembrane serine protease TMPRSS2 activates hepatitis C virus infectionHepatology, 2014
- Community acquired respiratory and gastrointestinal viral infectionsCurrent Opinion in Infectious Diseases, 2012
- Drug induced liver injury and its relationship to autoimmune hepatitisJournal of Hepatology, 2011
- Follicular Helper CD4 T Cells (TFH)Annual Review of Immunology, 2011
- Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining PrognosisGastroenterology, 2010
- The Immunobiology of SARSAnnual Review of Immunology, 2007
- Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2Gut, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- SARS-associated viral hepatitis caused by a novel coronavirus: Report of three casesHepatology, 2004
- Severe acute respiratory syndrome and the liverHepatology, 2004